Profile data is unavailable for this security.
About the company
AroCell publ AB is a Sweden-based diagnostic Company engaged in the development of markers for determination of cell growth (TK 210) and apoptosis. The Company's principal product candidate, TK-immuno/hem, is a test for monitoring and follow up of blood cancer. The test is based on a patented technology, which have already been evaluated in an early product prototype ELISA method. Apart from that, the Company develops a marker for solid tumor cancer disease. The AroCell cooperates with partners within development, production and sales.
- Revenue in SEK (TTM)30.41m
- Net income in SEK-62.15m
- Incorporated2000
- Employees--
- LocationAroCell AB (publ)Karlsbodavagen 39BROMMA 168 67SwedenSWE
- Phone+46 18503020
- Websitehttps://arocell.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Klaria Pharma Holding AB (publ) | 0.00 | -89.99m | 126.38m | -- | -- | 1.71 | -- | -- | -1.54 | -1.54 | 0.00 | 0.623 | 0.00 | -- | -- | -- | -85.46 | -29.15 | -132.95 | -33.67 | -- | -- | -- | -2,713.74 | -- | -16.67 | 0.0211 | -- | -- | -- | -4.07 | -- | -- | -- |
| PCI Biotech Holding ASA | 4.94m | -76.43m | 130.12m | 17.00 | -- | 1.97 | -- | 26.31 | -1.97 | -1.97 | 0.1273 | 1.70 | 0.0416 | -- | 0.5862 | 279,529.40 | -64.25 | -33.17 | -72.79 | -36.55 | -- | -- | -1,545.58 | -762.80 | -- | -- | 0.0221 | -- | -14.86 | -9.75 | -22.36 | -- | -- | -- |
| Isofol Medical AB (publ) | 15.65m | -195.59m | 131.15m | 15.00 | -- | 0.7135 | -- | 8.38 | -4.22 | -4.22 | 0.124 | 1.14 | 0.0441 | -- | 1.17 | 1,043,000.00 | -55.10 | -61.04 | -69.25 | -74.66 | -1,086.11 | -- | -1,250.18 | -1,186.01 | -- | -- | 0.0023 | -- | -39.63 | -- | -5.96 | -- | -- | -- |
| Toleranzia AB | 0.00 | -8.14m | 132.38m | -- | -- | 1.09 | -- | -- | -0.0673 | -0.0673 | 0.00 | 1.10 | 0.00 | -- | -- | -- | -6.19 | -12.63 | -6.43 | -13.30 | -- | -- | -- | -- | -- | -- | 0.0069 | -- | -- | -- | -27.68 | -- | 55.48 | -- |
| 2cureX AB | 8.00k | -28.86m | 139.59m | -- | -- | 2.75 | -- | 17,448.89 | -1.76 | -1.76 | 0.0005 | 2.88 | 0.0001 | -- | 0.0011 | -- | -42.42 | -23.18 | -44.73 | -27.65 | -176,600.00 | -88,517.02 | -360,787.50 | -94,872.34 | -- | -- | 0.00 | -- | -- | -- | -158.70 | -- | -37.81 | -- |
| Coegin Pharma AB | 0.00 | -35.59m | 146.00m | -- | -- | 5.98 | -- | -- | -0.0516 | -0.0516 | 0.00 | 0.0264 | 0.00 | -- | -- | -- | -142.04 | -- | -158.13 | -- | -- | -- | -- | -- | -- | -1,546.57 | 0.00 | -- | -- | -- | 41.29 | -- | -- | -- |
| Xintela AB | 0.00 | -78.22m | 150.71m | -- | -- | -- | -- | -- | -0.5315 | -0.5315 | 0.00 | -0.0085 | 0.00 | -- | -- | -- | -302.11 | -119.65 | -559.20 | -180.99 | -- | -- | -- | -12,122.00 | 0.3763 | -17.76 | -- | -- | -- | -- | -19.76 | -- | 27.36 | -- |
| Aqua Bio Technology ASA | 1.68m | -23.62m | 155.11m | 2.00 | -- | 19.61 | -- | 92.49 | -1.13 | -1.13 | 0.0804 | 0.3677 | 0.0644 | 0.6606 | 1.50 | -- | -90.75 | -73.71 | -152.91 | -100.31 | -117.42 | -41.86 | -1,408.30 | -2,046.06 | 0.3127 | -12.49 | 0.4955 | -- | 250.98 | -- | -33.32 | -- | 56.78 | -- |
| Peptonic Medical AB | 36.14m | -73.58m | 157.78m | -- | -- | 0.9062 | -- | 4.37 | -0.2277 | -0.2277 | 0.1075 | 0.1435 | 0.4188 | 1.04 | 3.39 | -- | -85.26 | -38.78 | -113.84 | -45.55 | 60.91 | -- | -203.61 | -223.58 | 0.5254 | -38.84 | 0.2223 | -- | -10.10 | -- | -115.39 | -- | -16.66 | -- |
| AroCell AB (publ) | 30.41m | -62.15m | 161.25m | -- | -- | 0.6746 | -- | 5.30 | -0.3854 | -0.3854 | 0.164 | 1.04 | 0.1224 | 4.76 | 8.63 | -- | -25.27 | -32.88 | -26.58 | -35.44 | -15.37 | -37.34 | -206.39 | -966.13 | 7.41 | -20,923.00 | 0.00 | -- | 14,180.95 | 194.00 | -107.99 | -- | -47.95 | -- |
| StenoCare A/S | 2.47m | -26.78m | 161.52m | -- | -- | 3.92 | -- | 65.36 | -1.53 | -1.53 | 0.1411 | 2.35 | 0.0389 | -- | 3.01 | -- | -42.17 | -- | -44.49 | -- | -- | -- | -1,083.68 | -- | 2.77 | -26.15 | 0.2065 | -- | 854.55 | -- | -8.03 | -- | -- | -- |
| New Nordic Healthbrands AB | 496.85m | -3.79m | 163.55m | 37.00 | -- | 1.41 | -- | 0.3292 | -0.6121 | -0.6121 | 80.20 | 18.74 | 1.95 | 4.13 | 3.96 | -- | -1.49 | 13.05 | -3.07 | 25.36 | 11.79 | 17.56 | -0.7632 | 5.29 | 0.9924 | -1.86 | 0.3082 | 38.87 | 14.39 | 10.98 | 19.92 | 17.35 | 35.33 | 25.59 |
| Combigene AB | 105.40m | 63.23m | 177.02m | -- | 2.80 | 1.08 | 2.69 | 1.68 | 3.19 | 3.19 | 5.32 | 8.29 | 0.764 | -- | 9.52 | -- | 45.84 | -19.29 | 47.74 | -24.55 | -- | -- | 60.00 | -55.85 | 24.54 | -- | 0.00 | -- | -- | -- | 171.35 | -- | -- | -- |
| Annexin Pharmaceuticals AB (publ) | 0.00 | -46.51m | 197.76m | 4.00 | -- | 5.98 | -- | -- | -0.4186 | -0.4186 | 0.00 | 0.2141 | 0.00 | -- | -- | -- | -178.18 | -118.13 | -224.56 | -143.44 | -- | -- | -- | -- | -- | -23.98 | 0.00 | -- | -- | -- | -17.86 | -- | -- | -- |
| Saniona AB | 14.86m | -333.55m | 199.63m | 25.00 | -- | 2.19 | -- | 13.44 | -5.35 | -5.35 | 0.2382 | 1.46 | 0.0409 | -- | 5.04 | 303,224.50 | -91.79 | -54.80 | -101.62 | -66.36 | -1,376.92 | -447.87 | -2,244.89 | -634.11 | -- | -27.61 | 0.473 | -- | 27.81 | -32.53 | -459.58 | -- | 12.71 | -- |
| Targovax ASA | 0.00 | -111.32m | 201.22m | 20.00 | -- | 0.5396 | -- | -- | -0.7255 | -0.7255 | 0.00 | 1.90 | 0.00 | -- | -- | 0.00 | -22.52 | -23.02 | -24.21 | -24.83 | -- | -- | -- | -21,183.60 | -- | -74.71 | 0.1444 | -- | -100.00 | -- | 9.39 | -- | -- | -- |
Data as of Jan 26 2023. Currency figures normalised to AroCell AB (publ)'s reporting currency: Swedish Krona SEK
0.35%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Arvernus Capital AGas of 31 Mar 2022 | 800.00k | 0.35% |
Data from 31 Mar 2022 - 31 Mar 2022Source: FactSet Research Systems Inc.
